J. Goldman & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 406 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 401 |
|
|
2024
Q4 | – | Sell |
-18,969
| Closed | -$2.11M | – | 399 |
|
|
2024
Q3 | $2.11M | Sell |
18,969
-57,916
| -75% | -$6.45M | 0.06% | 153 |
|
|
2024
Q2 | $8.21M | Buy |
+76,885
| New | +$8.21M | 0.23% | 100 |
|
|
2024
Q1 | – | Sell |
-36,497
| Closed | -$4.49M | – | 335 |
|
|
2023
Q4 | $4.49M | Buy |
+36,497
| New | +$4.49M | 0.18% | 95 |
|
|
2021
Q1 | – | Sell |
-12,586
| Closed | -$2.08M | – | 372 |
|
|
2020
Q4 | $2.08M | Buy |
12,586
+5,101
| +68% | +$842K | 0.11% | 149 |
|
|
2020
Q3 | $1.07M | Sell |
7,485
-12,940
| -63% | -$1.84M | 0.07% | 154 |
|
|
2020
Q2 | $2.25M | Buy |
+20,425
| New | +$2.25M | 0.14% | 114 |
|
|
2017
Q4 | – | Sell |
-7,500
| Closed | -$1.1M | – | 273 |
|
|
2017
Q3 | $1.1M | Sell |
7,500
-7,800
| -51% | -$1.14M | 0.06% | 132 |
|
|
2017
Q2 | $2.38M | Sell |
15,300
-50,400
| -77% | -$7.84M | 0.13% | 96 |
|
|
2017
Q1 | $9.54M | Buy |
65,700
+26,200
| +66% | +$3.8M | 0.47% | 31 |
|
|
2016
Q4 | $4.31M | Sell |
39,500
-32,300
| -45% | -$3.52M | 0.29% | 59 |
|
|
2016
Q3 | $8.72M | Buy |
71,800
+7,800
| +12% | +$948K | 0.49% | 31 |
|
|
2016
Q2 | $9.04M | Buy |
+64,000
| New | +$9.04M | 0.47% | 26 |
|